Ahead of SynBioBeta 2026, the AB4S Molecule Manifesto team argues that the longstanding scaling challenges in industrial biotechnology may soon be overcome by focusing on four molecule families: terpenes, peptides, non-catalytic proteins, and hydroxy acids. After extensive research, these molecules were selected based on their market potential, economic viability, and sustainability impact. The report highlights terpenes as a quick win and peptides as a long-term opportunity, emphasizing the need for alignment among stakeholders, including CPG brands, investors, and policymakers, to drive sector growth. The coalition aims for significant revenue generation by 2031, contingent on decisive action from industry leaders.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.synbiobeta.com/read/the-four-molecules-to-scale-for-industrial-biotech
